Hanne Melgaard Nielsen

Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group

Marianne Kyndi, Flemming Brandt Sørensen, Helle Knudsen et al. · Journal of Clinical Oncology · 2008 · 571 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials

Marie Overgaard, Hanne Melgaard Nielsen, Jens Overgaard · Radiotherapy and Oncology · 2007 · 440 citations

Medicine, Oncology, Radiation Oncology +17

Study of Failure Pattern Among High-Risk Breast Cancer Patients With or Without Postmastectomy Radiotherapy in Addition to Adjuvant Systemic Therapy: Long-Term Results From the Danish Breast Cancer Cooperative Group DBCG 82 b and c Randomized Studies

Hanne Melgaard Nielsen, Marie Overgaard, Cai Grau et al. · Journal of Clinical Oncology · 2006 · 349 citations

Medicine, Oncology, Radiation Oncology +17

Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial

Birgitte Vrou Offersen, Jan Alsner, Hanne Melgaard Nielsen et al. · Journal of Clinical Oncology · 2020 · 268 citations

Medicine, Oncology, Radiation Oncology +12

Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group

Mette Holck Nielsen, Martin Berg, Anders N. Pedersen et al. · Acta Oncologica · 2013 · 204 citations · Full text

Medicine, Oncology, Radiation Oncology +17